Baker Bros. Advisors’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-102,205
Closed -$2.86M 115
2019
Q3
$2.86M Buy
102,205
+2,800
+3% +$78.3K 0.02% 80
2019
Q2
$1.4M Buy
+99,405
New +$1.4M 0.01% 91